A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Clinical trial NCT04548999 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04548999
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-03
- Primary completion
- 2025-06-30
- Enrollment
- 769
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.